Skip to main content
OpenTrials
Completed

NCT Number: NCT00568386

Acute Comfort and Blur of Systane and Optive

To evaluate drop comfort, acceptability, preference and blur profile between two marketed artificial tears in both dry eye and non-dry eye patient population.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Dry Eye Dry Eye Syndromes Eye Diseases Lacrimal Apparatus Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Healthy, normal eyes OR documented diagnosis of dry eye

Exclusion criteria

  • Must not have worn contact lenses for 7 days preceding enrollment

Treatment and study plan

Systane Lubricant Eye Drops

Other

Systane Lubricant Eye Drops 1 drop each eye once time

Optive lubricant Eye Drops

Other

Optive Lubricant Eye Drops 1 drop each eye one time

Primary outcomes

  1. Visual Blur

    Time frame: 3 minutes post dose

    Visual blur profile is a visual scale ranging from 0 (no blur) to 50 (most blurry). Patients were asked to rate there vision on a specific focal point (an object in the room) through 3 minutes.

Sponsors and collaborators

Lead sponsor

Alcon Research

Industry

Registry information

Official study title

Acute Comfort and Blurring Profile Evaluation Comparing Systane Lubricant Eye Drops to Optive Lubricant Eye Drops

Important dates

Study start
2007
Study completion
2007
First posted
Dec 6, 2007
Registry last updated
Feb 2, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.